[Trials of active immunotherapy in the treatment of acute lymphoid leukemia: influence of diverse factors on the results]. 1973

G Mathé, and P Pouillart, and L Schwarzenberg

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's

Related Publications

G Mathé, and P Pouillart, and L Schwarzenberg
January 1973, Archives francaises de pediatrie,
G Mathé, and P Pouillart, and L Schwarzenberg
January 1977, European journal of cancer,
G Mathé, and P Pouillart, and L Schwarzenberg
January 1976, Lancet (London, England),
G Mathé, and P Pouillart, and L Schwarzenberg
June 1972, Revue medicale de la Suisse romande,
G Mathé, and P Pouillart, and L Schwarzenberg
January 1982, Revista espanola de oncologia,
G Mathé, and P Pouillart, and L Schwarzenberg
January 1981, Neoplasma,
G Mathé, and P Pouillart, and L Schwarzenberg
January 1996, La Revue du praticien,
G Mathé, and P Pouillart, and L Schwarzenberg
January 1996, La Revue du praticien,
G Mathé, and P Pouillart, and L Schwarzenberg
July 1980, British journal of haematology,
G Mathé, and P Pouillart, and L Schwarzenberg
February 1993, Sangre,
Copied contents to your clipboard!